Laxmi Dental Limited
Minimum investment
Bidding date
13 Jan - 15 Jan 2025
Price range
—
Minimum quantity
33
Minimum investment
₹13,431
Issue size
—
IPO doc (link)
RHP docsListing exchange
NSE/BSE
Laxmi Demtal Limited is India’s only end-to-end integrated dental products company offering a comprehensive portfolio of dental products. The offerings include custom-made crowns 247 and bridges, branded dental products such as clear aligners, thermoforming sheets and aligner related products, and paediatric dental products. They have a brand presence of more than 20 years and are amongst the top two largest dental laboratories in India.
They are a vertically integrated dental aligner company, and the largest and most profitable indigenous B2B2C dental aligner company in terms of revenue from operations and PAT Margin for the Fiscal 2023. Company manufactures its dental products across six manufacturing facilities spread over 146,800 square feet.
Integrated dental products company: Laxmi Dental Limited is India’s only end-to-end integrated dental products company offering a comprehensive portfolio of dental products. Its portfolio includes custom-made crowns and bridges, branded dental products such as clear aligners and paediatric dental products.
Second largest player: Laxmi Dental is amongst the top two largest dental laboratories in India. Its laboratory has a brand presence of 20+ years in the dental lab business and has evolved from a dental lab with a few members to an integrated dental products company.
Vertically integrated: Company has invested in brand building to build awareness and customer connect. Due to more than two decades in the dental industry and high-quality dental products, company has been able to scale their branded product portfolio.
Large dental network: Company has built a large Dental Network with a reach of over 20,000 dental clinics, dental companies and dentists and have catered to global and domestic demand by exporting their products.
Export : Exports account for a significant portion of company's revenues. A failure to manage business in overseas markets or inability to grow business in new geographic markets may affect company's growth, which could have a adverse effect on business.
Network dependence: Company's dental products are primarily recommended through its Dental Network to end customers, and any change in their recommendations may adversely affect our business.
Active IPOs | |
|---|---|
Company name | Bid starts |
Citius Transnet Investment Trust | 17-04-2026 |